The Gleason 6 “cancer” fails to act as cancer.

Despite low-power microscopic appearances suggesting a mild cancer, the very common Gleason grade 3 as in the Gleason 3+3 = 6 “cancer” fails to act like a cancer.

  • The Gleason 6 or, G6 lacks the hallmarks of cancer on both clinical and molecular biology grounds  
  • The G6 cell has a very long doubling-time of 475 +/-­ 56 days so that from mutation to a growth of about one cm (smaller than half an inch) in diameter takes some 40 years
  • About 50 percent of 50 year-old-men have unrecognized and asymptomatic areas of G6 disease in their prostate
  • The prevalence of G6 increases with age
  • That the G6 fails to evolve and harm men suggests it’s part of the aging process
  • Because of these findings, there is no justification for continuing to call the Gleason 6 either a cancer or a low-risk cancer
  • Because of this knowledge the G6 doesn’t need treatment. In fact, those unfortunate men who were treated for their Gleason 6 disease are survivors of their treatment and not survivors of the bogus cancer
  • All prostate cancer statistics are false as they include the G6 pseudo-cancer
  • Only some high-grade prostate cancers are potentially deadly

Find a direct pay urologist near you for more information and visit

Come join our healthcare community. 

Read more.

Written by HEALTHdrum